Peter Agnes

Active Investor

Group Head of Portfolio Finance & Operating Partner, Life Sciences at B-FLEXION

Boston, Massachusetts

Peter Agnes, Group Head of Portfolio Finance & Operating Partner, Life Sciences at B-FLEXION is an active investor based in Boston, Massachusetts. This profile covers what Peter Agnes backs, at which stage, and how founders can reach out in 2026.

Mr. Peter Agnes serves as interim Chief Financial Officer at Boston Pharmaceuticals. Mr. Agnes served as Operating Partner - Group Investment Office & Group Finance at B-FLEXION Life Sciences. He served as Chief Operating Officer & Operating Partner at Gurnet Point Capital. He serves as Executive Board Member at Will Ventures. He served as Advisor at Essentia Analytics.

Investor type: AngelVCPEHedge Fund
Stages: Pre SeedSeedSeries ASeries BLate Stage Venture
Invests in: Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaSaaS & EnterpriseIoT & Connected DevicesPropTech & Real Estate
Location: Boston, Massachusetts
Typical check: $1M
Past investments: 13

Notable investments

Corium InnovationsBarclays CapitalCoriumWill VenturesNaveris, Inc.Gurnet Point CapitalSlyceDataBoston PharmaceuticalsRadius Health, Inc.UBSEssentia AnalyticsAuregen BioTherapeutics

How to reach Peter Agnes

Angels and operators like Peter Agnes reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Peter Agnes invest in?

Peter Agnes invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and SaaS & Enterprise, typically at Pre Seed, Seed, Series A and Series B. Match your sector and stage, then reach out with a personalized pitch.